-
Cell Therapy Market to Reach $48B by 2033, Fueled by CAR-T Expansion, Chronic Disease Burden, Precision Medicine Demand
31 Jul 2025 13:00 GMT
… pharmaceutical companies, are enhancing research capabilities and commercialization efforts.
• Personalized Medicine … due to rising healthcare expenditure, expanding … IOVANCE Biotherapeutics, Inc., Dendreon Pharmaceuticals LLC., Enzyvant Therapeutics …
-
Lee A. Tafoya On Why Clinical Experience Should Be A Prerequisite For Healthcare Executives
05 Jul 2025 12:42 GMT
… stakes cancer trials, home health leadership, and international medical relief; he… oncology studies, including the renowned Dendreon cancer trials. His technical expertise … nurse leaders, medical directors, and patient advocates
“Healthcare is not just …
-
Cancer Vaccine (Preventative, Therapeutic) Market Research 2021-2031 | Innovations Drives the Industry Forward - Precision Immunotherapy and Personalized Medicine in Focus - ResearchAndMarkets.com
04 Jul 2025 18:51 GMT
… investment in personalized medicine and biologics.
Preventative … cancer incidence, increasing healthcare expenditure, and expanding … -Track and Orphan Drug Designations
Competitive Positioning: … Inc.
BioNTech SE
Dendreon Pharmaceuticals LLC
Gritstone bio, Inc …
-
Rising Beyond Boundaries; How Lee Tafoya Is Reimagining Healthcare Through Compassion, Strategy, and Service
19 Jun 2025 04:19 GMT
… Washington Hospital Center’s Medical-Psychiatric Unit, Lee … immunology. His work on Dendreon cancer trials, which … then, that Lee approaches healthcare through a similarly multidimensional … dedicated volunteer with International Medical Relief (IMR), he …
-
Translating Transfusion-Medicine Technology to Cancer-Vaccine Manufacturing: A Novel Immunization Approach Based on Inactivated Autologous Tumor Cells
08 May 2025 12:24 GMT
… for translating transfusion-medicine technologies to biopharmaceutical … help both patients and healthcare providers. But after … US Food and Drug Administration (FDA) clearance on an … for Advanced Prostate Cancer. Dendreon Pharmaceuticals: Seal Beach, CA, …
-
Real-World Relugolix Adherence Rates Are High in Patients on Medicare With Prostate Cancer
17 Feb 2025 18:03 GMT
… MD, FASCO, medical oncologist, UC San Diego Health, and professor, … Calithera Biosciences, Caris Life Sciences, Dendreon, Esiai, Exelixis, Janssen, Lilly … Sorrento Therapeutics, Sumitomo Pharma Oncology, Telix Pharmaceuticals, Tempus, and Vividion …
-
Hormone Sensitive Advanced Prostate Cancer Treatment Market 2032: FDA Approvals, Clinical Trials, drugs by DelveInsight
08 Jan 2025 12:39 GMT
… Novartis Pharmaceuticals, Merc & Co., Inc., Bristol-Myers, Dendreon Corporation … Advanced Prostate Cancer Drugs Uptake and Pipeline … Cancer Current Treatment and Medical Practices
10. Hormone … DelveInsight is a leading Healthcare Business Consultant, and …
-
Drug and Gene Delivery Devices Market CAGR of 11.6% Share, Trends, Growth And Forecast By 2024 To 2031 | Pfizer, Inc.
10 Dec 2024 14:45 GMT
… Human Stem Cell Institute
• Dendreon Pharmaceuticals
• Helixmith Co.
• … Drugs: Luxturna (Drug Delivery Devices), Yescarta (Drug Delivery Devices), Zolgensma (Drug Delivery Devices), Kymriah (Drug … and technology, healthcare, chemical and materials …
-
Zentalis Pharmaceuticals Announces Executive Leadership Changes Supporting Planned Registrational Clinical Studies of Azenosertib
13 Nov 2024 13:00 GMT
… publicly traded biotechnology companies including Dendreon and Amgen. Ms. Eastland … has worked in the global pharmaceutical and medical technology industries for nearly … in Germany. About Zentalis Pharmaceuticals
Zentalis® Pharmaceuticals, Inc. is a clinical …
-
Chinese pharma companies eyeing strong foothold in therapeutic cancer vaccines market
26 Aug 2024 06:58 GMT
… and liver cancers.
Jithendra Kancharla, Pharma Analyst, GlobalData, commented, “Therapeutic … T (Provenge), developed by Dendreon Pharmaceuticals, for the treatment of advanced … FDA-approved therapeutic cancer vaccine.
According to GlobalData’s Pharmaceutical …
About
© 1995-2025